Medcann Pharma Inc. is a business group with headquarters in Canada and subsidiaries in Spain, Peru and Colombia, where its Production and Operations Centre is located.
The group projects itself as a global powerhouse in genetics licensing and seed supply, building on our current and future capabilities and our key competitive advantages: our regulatory assets, human talent and ambitious research and development projects.
Medcann Europe aims to leverage the development of the genetics business line on the continent, taking advantage of the medical cannabis cultivation initiatives being implemented in Europe and through large-scale collaborative R&D&I projects with multiple stakeholders. These alliances will play a decisive and strategic role in facilitating the advancement and acquisition of knowledge about medical cannabis – its genetic and agricultural improvement – and the generation of evidence about its therapeutic effects and the health conditions that it can help to alleviate, making the Basque Country a research and development hub in this sector.